RENAVIS Trademark

Trademark Overview

On Thursday, April 8, 2021, a trademark application was filed for RENAVIS with the United States Patent and Trademark Office. The USPTO has given the RENAVIS trademark a serial number of 90631907. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 25, 2023. This trademark is owned by Adi, Chudi. The RENAVIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software using artificial intelligence for telemedicine and remote monitoring of patients with kidney disease
renavis

General Information

Serial Number90631907
Word MarkRENAVIS
Filing DateThursday, April 8, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements

Pseudo MarkRENA VIS
Goods and ServicesSoftware as a service (SAAS) services featuring software using artificial intelligence for telemedicine and remote monitoring of patients with kidney disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code042
First Use Anywhere DateThursday, April 1, 2021
First Use In Commerce DateTuesday, June 1, 2021

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressAlbuquerque, NM 87122
Party NameAdi, Chudi
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlbuquerque, NM 87122

Trademark Events

Event DateEvent Description
Tuesday, April 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 25, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022SU - NON-FINAL ACTION - WRITTEN
Friday, September 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 4, 2022NON-FINAL ACTION E-MAILED
Monday, April 4, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, March 30, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 2, 2022USE AMENDMENT FILED
Tuesday, March 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 2, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, March 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 7, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, January 26, 2022ASSIGNED TO PETITION STAFF
Friday, January 14, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 28, 2021ASSIGNED TO EXAMINER
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 12, 2021NEW APPLICATION ENTERED

Related Keywords

renavis software remote monitoring patients disease kidney telemedicine artificial saas service